Fraud and anti-money laundering (AML) capabilities have advanced significantly in recent years. Yet in many institutions the two functions still operate on separate data, systems and incentives, ...

Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma To our knowledge, this is the ...

Panelists discuss how current NCCN guidelines emphasize the importance of treating AML at experienced centers with proper infrastructure, while treatment decisions are based on intensive vs ...

Financial institutions are discovering an unlikely ally in the war against dirty money: environmental, social, and governance (ESG) standards. As criminals funnel an estimated $110-$281 billion ...